Cancer metabolism at a glance
- PMID: 27635066
- PMCID: PMC6518336
- DOI: 10.1242/jcs.181016
Cancer metabolism at a glance
Abstract
A defining hallmark of cancer is uncontrolled cell proliferation. This is initiated once cells have accumulated alterations in signaling pathways that control metabolism and proliferation, wherein the metabolic alterations provide the energetic and anabolic demands of enhanced cell proliferation. How these metabolic requirements are satisfied depends, in part, on the tumor microenvironment, which determines the availability of nutrients and oxygen. In this Cell Science at a Glance paper and the accompanying poster, we summarize our current understanding of cancer metabolism, emphasizing pathways of nutrient utilization and metabolism that either appear or have been proven essential for cancer cells. We also review how this knowledge has contributed to the development of anticancer therapies that target cancer metabolism.
Keywords: Cancer; Metabolism; Targeted therapy.
© 2016. Published by The Company of Biologists Ltd.
Conflict of interest statement
Eyal Gottlieb is a shareholder and consultant at MetabMed Ltd, Israel.
References
-
- Bertagnolli M. M., Hsu M., Hawk E. T., Eagle C. J. and Zauber A. G. and Adenoma Prevention with Celecoxib Study Investigators. (2010). Statin use and colorectal adenoma risk: results from the adenoma prevention with celecoxib trial. Cancer Prev. Res. 3, 588-596. 10.1158/1940-6207.CAPR-09-0271 - DOI - PMC - PubMed
-
- Bolusani S., Young B. A., Cole N. A., Tibbetts A. S., Momb J., Bryant J. D., Solmonson A. and Appling D. R. (2011). Mammalian MTHFD2L encodes a mitochondrial methylenetetrahydrofolate dehydrogenase isozyme expressed in adult tissues. J. Biol. Chem. 286, 5166-5174. 10.1074/jbc.M110.196840 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources